Buscar
Mostrando ítems 1-10 de 2370
Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver DiseaseFructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease
(2020)
Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of liver disease in both adults and children, becoming the leading cause for liver transplant in many countries. Its prevalence has increased ...
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
(Elsevier, 2020)
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the general population. Furthermore, its prevalence ...
Genetic basis of alcoholic and nonalcoholic fatty liver disease
(Springer, 2015)
The abnormal deposition of triglycerides in the liver is known as fatty liver. While the transformationof fatty liver may occur owing to a number of factors, it is often associated either with metabolic risk factors of the ...
Impact of the co-administration of N-3 fatty acids and olive oil components in preclinical nonalcoholic fatty liver disease models: a mechanistic view
(MDPI, 2020)
Nonalcoholic fatty liver disease (NAFLD) is present in approximately 25% of the population worldwide. It is characterized by the accumulation of triacylglycerol in the liver, which can progress to steatohepatitis with ...
A global action agenda for turning the tide on fatty liver disease
(Wolters Kluwer Health, 2023)
Background and Aims: Fatty liver disease is a major public health threat due to its very high prevalence and related morbidity and mortality. Focused and dedicated interventions are urgently needed to target disease ...
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease Mecanismos moleculares de la esteatosis en la patología de hígado graso no alcohólico
(Grupo Aula Medica S.A., 2011)
Nonalcoholic fatty liver disease (NAFLD) is the most important cause of chronic liver disease and is considered the hepatic manifestation of the metabolic syndrome associated with diabetes mellitus type 2. The prevalence ...
Mechanism lipotoxicity in the progression from fatty liver to non-alcoholic steatohepatitis
(Nova Science Publishers, 2017)
Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease worldwide. A subset of these individuals develops hepatocyte damage, inflammation and fibrosis, a syndrome referral as ...